注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
杭州启明医疗器械股份有限公司是一家从事用于治疗心脏瓣膜疾病的微创医疗设备以及辅助仪器和设备的研发、制造和销售的中国公司。该公司的主要产品包括VenusA-Valve系統,VenusA-Plus系統,VenusA-Pilot系統,VenusP-Valve系統,TMVR 瓣膜, TTVR 瓣膜,瓣膜成形术球囊V8 / TAV8及TriGUARD3脑栓塞保护仪器。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Liu Meirong | 48 | 2023 | Executive Director |
Liqiao Ma | - | 2023 | Executive Director |
Martin B. Leon | - | - | Member of Advisory Board |
Chi Wai Suen | 59 | 2019 | Independent Non-Executive Director |
Ting Yuk Wu | 70 | 2018 | Independent Non-Executive Director |
Zhang Ao | 39 | 2023 | Non-Executive Director |
Wei Wang | 41 | 2018 | Shareholders Representative Supervisor |
Scott Lim | - | 2020 | Member of Global Advisory Board |
Yue Li | 34 | 2022 | Shareholders Representative Supervisor |
Chaim Lotan | 72 | 2020 | Member of Global Advisory Board |
Min Shao | 50 | 2022 | Employee Representative Supervisor |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核